1. CEUS LI-RADS are effective in predicting the risk hepatocellular carcinoma of liver nodules. Issue 1 (16th February 2017) Authors: Terzi, E.; De Bonis, L.; Leoni, S.; Benevento, F.; Granito, A.; Tovoli, F.; Pini, P.; Bolondi, L.; Piscaglia, F. Journal: Digestive and liver disease Issue: Volume 49:Issue 1(2017)Supplement Page Start: e22 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Impact of gadoxetic acid (Gd‐EOB‐DTPA)‐enhanced magnetic resonance on the non‐invasive diagnosis of small hepatocellular carcinoma: a prospective study. Issue 3 (2nd December 2012) Authors: Granito, A.; Galassi, M.; Piscaglia, F.; Romanini, L.; Lucidi, V.; Renzulli, M.; Borghi, A.; Grazioli, L.; Golfieri, R.; Bolondi, L. Journal: Alimentary pharmacology & therapeutics Issue: Volume 37:Issue 3(2013) Page Start: 355 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Increased risk of nonalcoholic fatty liver disease in patients with coeliac disease on a gluten‐free diet: beyond traditional metabolic factors. Issue 5 (8th July 2018) Authors: Tovoli, F.; Negrini, G.; Farì, R.; Guidetti, E.; Faggiano, C.; Napoli, L.; Bolondi, L.; Granito, A. Journal: Alimentary pharmacology & therapeutics Issue: Volume 48:Issue 5(2018) Page Start: 538 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. OC.12.4 PROGNOSTIC FACTORS IN PATIENTS WITH HEPATOCELLULAR CARCINOMA (HCC) TREATED WITH LENVATINIB. (March 2023) Authors: Sacco, R.; Ciruolo, M.; Paolillo, R.; Ramai, D.; Tortora, R.; Di, Costanzo G.G.; Burlone, M.; Pirisi, M.; Federico, P.; Daniele, B.; Silletta, M.; Gallo, P.; Cocuzza, C.; Russello, M.; Cabibbo, G.; Cesario, S.; Masi, G.; Marzi, L.; Mega, A.; Granito, A. Journal: Digestive and liver disease Issue: Volume 55(2023)Supplement 2 Page Start: S119 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. P.09.16 LONG-TERM SORAFENIB TREATMENT IN A LARGE COHORT OF HCC PATIENTS: A MULTICENTER STUDY. Issue 2 (15th March 2018) Authors: Sacco, R.; Granito, A.; Zolfino, T.; Saitta, C.; Marzi, L.; Metrangolo, S.; Parisi, G.; Tumino, E.; Bresci, G.; Cabibbo, G. Journal: Digestive and liver disease Issue: Volume 50:Issue 2(2018)Supplement Page Start: e222 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Pattern of progression of intrahepatic cholangiocarcinoma impacts on survival: Implications for second-line trials. (March 2021) Authors: Tovoli, F.; Garajovà, I.; Iavarone, M.; Federico, P.; Gelsomino, F.; Granito, A.; Daniele, B.; Forgione, A.; Piscaglia, F. Journal: Digestive and liver disease Issue: Volume 53:(2021)Supplement 1 Page Start: S19 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Prognostic impact of metastatic site in patients receiving first-line sorafenib therapy for advanced hepatocellular carcinoma. (March 2023) Authors: Ielasi, L.; Tovoli, F.; Stefanini, B.; Tortora, R.; Magini, G.; Sacco, R.; Pressiani, T.; Trevisani, F.; Piscaglia, F.; Granito, A. Journal: Digestive and liver disease Issue: Volume 55(2023)Supplement 1 Page Start: S42 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Prognostic impact of previous intraarterial treatment in patients with hcc treated with sorafenib. (March 2023) Authors: Stefanini, B.; Ielasi, L.; Pressiani, T.; Trevisani, F.; Sacco, R.; Gardini, A. Casadei; Magini, G.; Di Costanzo, G.G.; Granito, A.; Tovoli, F.; Piscaglia, F. Journal: Digestive and liver disease Issue: Volume 55(2023)Supplement 1 Page Start: S54 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Prognostication of hepatocellular carcinoma under sorafenib: external validation of the PROSASH-II model. (February 2020) Authors: Sansone, V.; Tovoli, F.; Casadei-Gardini, A.; Di Costanzo, G.G.; Magini, G.; Sacco, R.; Pressiani, T.; Trevisani, F.; Tortora, R.; Ielasi, L.; Granito, A. Journal: Digestive and liver disease Issue: Volume 52(2020)Supplement 1 Page Start: e15 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Real-life clinical data of cabozantinib for unresectable hepatocellular carcinoma: efficacy, safety and prognostic factors. (March 2021) Authors: Tovoli, F.; Dadduzio, V.; De Lorenzo, S.; Rimassa, L.; Masi, G.; Iavarone, M.; Marra, F.; Garajova, I.; Brizzi, M.P.; Daniele, B.; Trevisani, F.; Messina, C.; Clemente, F. Di; Pini, S.; Cabibbo, G.; Granito, A.; Rizzato, M.D.; Zagonel, V.; Brandi, G.; Pressiani, T. Journal: Digestive and liver disease Issue: Volume 53:(2021)Supplement 1 Page Start: S10 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗